Table 3.
Gonorrhea (NG)/chlamydia (CT) testing episodes associated with presumptive treatment*, by anatomic site of testing and clinical characteristics, STD Surveillance Network, 2015-2018.
| Anatomic Site of Testing | Clinical Characteristics | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Urethral Testing only |
Extragenital Testing only |
Urethral + Extragenital Testing |
Unknown anatomic site |
Symptomatic+ only |
Contact to Partner with STI only |
Symptomatic+ + Contact to Partner with STI |
Not symptomatic+ or Contact to Partner with STI |
|||||||||
| # | % | # | % | # | % | # | % | # | % | # | % | # | % | # | % | |
| MSM (n=21,707) | 2,635 | 12.1 | 1,244 | 5.7 | 17,826 | 82.1 | 2 | 0.01 | 7,631 | 35.2 | 8,277 | 38.1 | 3,557 | 16.4 | 2,242 | 10.3 |
| Heterosexual men (n=23,972) | 12,368 | 51.6 | 159 | 0.7 | 11,437 | 47.7 | 8 | 0.03 | 13,567 | 56.0 | 6,351 | 26.5 | 2,594 | 10.8 | 1,460 | 6.1 |
| Women (n=8,769) | 3,396 | 39.8 | 189 | 2.2 | 5,139 | 60.2 | 45 | 0.5 | 3,041 | 34.7 | 2,893 | 33.0 | 2,081 | 23.7 | 754 | 8.6 |
| Total (54,448) | 18,399 | 34.9 | 1,592 | 2.9 | 34,402 | 65.2 | 55 | 0.1 | 24,239 | 47.0 | 17,521 | 32.2 | 8,232 | 15.1 | 4,456 | 8.2 |
*
Does not include those episodes among patients who had a positive gram stain.
+
Symptomatic is defined as STD-related symptoms (including vaginal/penile/anal discharge, dysuria, genital pain, sores/ulcers, rashes, itching, or foul odor, lower abdominal pain).
ACRONYMS: MSM=gay, bisexual, and other men who have sex with men; STI=sexually transmitted infection